XML 18 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Mar. 16, 2023
Jun. 30, 2022
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Entity Shell Company false    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
EntityWellKnownSeasonedIssuer No    
Entity Interactive Data Current Yes    
Document Period End Date Dec. 31, 2022    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Current Fiscal Year End Date --12-31    
ICFR Auditor Attestation Flag false    
Entity Registrant Name Landos Biopharma, Inc.    
Entity Incorporation State Country Code DE    
Entity Address, Address Line One P.O. Box 11239    
Entity Address, City or Town Blacksburg    
Entity Address, State or Province VA    
Entity Tax Identification Number 81-5085535    
Entity Address, Postal Zip Code 24062    
City Area Code 540    
Local Phone Number 218-2232    
Title of 12(b) Security Common stock, par value $0.01 per share    
Trading Symbol LABP    
Entity Public Float     $ 8.5
Security Exchange Name NASDAQ    
Entity Filer Category Non-accelerated Filer    
Entity File Number 001-39971    
Entity Small Business true    
Entity Central Index Key 0001785345    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
Entity Common Stock, Shares Outstanding   31,168,449  
Auditor Name Ernst & Young LLP    
Auditor Location Raleigh, North Carolina    
Auditor Firm ID 42